Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
clinical trials
3
×
life sciences
national blog main
avapritinib
blueprint medicines
boston top stories
fda
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
aminolevulinic acid
andrew berens
biotech
cancer
cstone pharmaceuticals
deals
deciphera pharmaceuticals
drugs
eli lilly
european medicines agency
fisogatinib
flatiron health
gastrointestinal stromal tumor
genentech
gist
givosiran
gleevec
hepatocellular carcinoma
imatinib
investing
jeff albers
medullary thyroid cancer
national top stories
non-small cell lung cancer
onpattro
patisiran
paul matteis
pralsetinib
What
approval
3
×
drug
fda
blueprint
cancer
medicine
seek
ago
alnylam
announced
candidate
chasing
currently
deadly
deciphera
filing
forms
gi
indicated
interference
marketing
medicines
morning
muscle
nod
pact
pharamceuticals
pharmaceuticals
plans
quick
regulatory
ret
review
rna
rnai
roche
second
speedy
team
treats
Language
unset
Current search:
boston
×
approval
×
" clinical trials "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug